Cargando…

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control

Glucagon-like peptide-1 (GLP-1) is an incretin hormone mainly secreted from intestinal L cells in response to nutrient ingestion. GLP-1 has beneficial effects for glucose homeostasis by stimulating insulin secretion from pancreatic beta-cells, delaying gastric emptying, decreasing plasma glucagon, r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Young-Sun, Jun, Hee-Sook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823510/ https://www.ncbi.nlm.nih.gov/pubmed/27110066 http://dx.doi.org/10.1155/2016/3094642

Ejemplares similares

GLP-1 Based Combination Therapy for Obesity and Diabetes
por: Lee, Young Hee, et al.
Publicado: (2017)

Anti-Inflammatory Effects of GLP-1R Activation in the Retina
por: Puddu, Alessandra, et al.
Publicado: (2022)

Adding GLP-1 Receptor Agonist Therapy to Basal Insulin for Postprandial Glucose Control
por: Rhinehart, Andrew S.
Publicado: (2015)

GLP-1 based therapies and disease course of inflammatory bowel disease
por: Villumsen, Marie, et al.
Publicado: (2021)

Mechanisms Controlling Glucose-Induced GLP-1 Secretion in Human Small Intestine
por: Sun, Emily W., et al.
Publicado: (2017)

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
por: Zhao, Xin, et al.
Publicado: (2021)

GLP-1a: Going beyond Traditional Use
por: Laurindo, Lucas Fornari, et al.
Publicado: (2022)

Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
por: Diz-Chaves, Yolanda, et al.
Publicado: (2022)

Glucolipotoxicity and GLP-1 secretion
por: Hong, Jung-Hee, et al.
Publicado: (2021)

Cardiovascular Benefits of GLP-1-BasedTherapies in Patients with Diabetes Mellitus Type 2: Effects on Endothelial and Vascular Dysfunction beyond Glycemic Control
por: Forst, Thomas, et al.
Publicado: (2012)

Glucose in the hypothalamic paraventricular nucleus regulates GLP-1 release
por: Ma, Yue, et al.
Publicado: (2020)

GLP-1 Receptor Agonists: Nonglycemic Clinical Effects in Weight Loss and Beyond
por: Ryan, Donna, et al.
Publicado: (2015)

Counselling Patients for GLP-1 Analogue Therapy: Comparing GLP-1 Analogue with Insulin Counselling
por: Kalra, Sanjay, et al.
Publicado: (2012)

Cardiovascular Benefits of Native GLP-1 and its Metabolites: An Indicator for GLP-1-Therapy Strategies
por: Li, Junfeng, et al.
Publicado: (2017)

Do GLP-1–Based Therapies Increase Cancer Risk?
por: Nauck, Michael A., et al.
Publicado: (2013)

Engineering an enhanced thrombin-based GLP-1 analog with long-lasting glucose-lowering and efficient weight reduction
por: Pan, Hongchao, et al.
Publicado: (2019)

Design and evaluation of novel thrombin-based GLP-1 analogs with peptidic albumin binding domain for the controlled release of GLP-1
por: Niu, Xianli, et al.
Publicado: (2020)

A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond
por: Prasad-Reddy, Lalita, et al.
Publicado: (2015)

GLP-1 Receptor Agonists in Type 2 Diabetes and Beyond – New Insights 2015
por: Gallwitz, Baptist
Publicado: (2015)

Attenuation of diabetic kidney injury in DPP4-deficient rats; role of GLP-1 on the suppression of AGE formation by inducing glyoxalase 1
por: Sarker, Mithun Kumer, et al.
Publicado: (2020)

Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
por: Lin, Chia-Hung, et al.
Publicado: (2015)

Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
por: Marathe, Chinmay S., et al.
Publicado: (2011)

Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery
por: Larraufie, Pierre, et al.
Publicado: (2019)

Endurance Training Improves GLP-1 Sensitivity and Glucose Tolerance in Overweight Women
por: Åkerström, Thorbjörn, et al.
Publicado: (2022)

Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases
por: Lee, Young-Sun, et al.
Publicado: (2018)

Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis
por: Yang, Li, et al.
Publicado: (2021)

Does GLP-1 suppress hepatocyte glucose production directly, via fibroblast growth factor 21?
por: Liu, Jun-Li, et al.
Publicado: (2019)

Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes
por: Lin, Chia-Hung, et al.
Publicado: (2015)

Resveratrol Increases Glucose Induced GLP-1 Secretion in Mice: A Mechanism which Contributes to the Glycemic Control
por: Dao, Thi-Mai Anh, et al.
Publicado: (2011)

GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence
por: Meloni, A R, et al.
Publicado: (2013)

GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
por: Yu, Ji Hee, et al.
Publicado: (2022)

Influence of GLP-1 on Myocardial Glucose Metabolism in Healthy Men during Normo- or Hypoglycemia
por: Gejl, Michael, et al.
Publicado: (2014)

Acute activation of GLP-1-expressing neurons promotes glucose homeostasis and insulin sensitivity
por: Shi, Xuemei, et al.
Publicado: (2017)

Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment
por: Gejl, Michael, et al.
Publicado: (2017)

Systematic Synergy of Glucose and GLP-1 to Stimulate Insulin Secretion Revealed by Quantitative Phosphoproteomics
por: Tang, Jia-shu, et al.
Publicado: (2017)

GLP-1 Inhibits High-Glucose-Induced Oxidative Injury of Vascular Endothelial Cells
por: Li, Quan, et al.
Publicado: (2017)

Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion
por: Yan, Shijun, et al.
Publicado: (2022)

GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice
por: Quarta, Carmelo, et al.
Publicado: (2022)

Contribution of GIP and GLP-1 to the Insulin Response to Oral Administration of Glucose in Female Mice
por: Ahrén, Bo
Publicado: (2023)

The Role of Anti-Inflammatory Adipokines in Cardiometabolic Disorders: Moving beyond Adiponectin
por: Jung, Han Na, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nqftqs9g5gj0r10gj1ksitb2rp